---
category: news
title: "Kiromic BioPharma Announces Strategic Collaboration with Gemelli Teaching Hospital to Accelerate the Analysis of Allogeneic CAR-T Clinical Trial Candidate Alexis ISO-1 in Solid ..."
excerpt: "Alexis ISO-1 is Companyâ€™s First Artificial Intelligence-identified, Gamma Delta T Cell Engineered Iso-Mesothelin Candidate to Address Solid Tumor Cancers HOUSTON-- ( BUSINESS WIRE )--Kiromic BioPharma,"
publishedDateTime: 2021-10-11T16:02:00Z
originalUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
webUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
type: article
quality: 0
heat: 0
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

secured: "e9c4T8OJB0qITgsCfsu0ZO52BumIT95CjTNgG181i1MEYd0L96RbrRWpyV5/OBLhf6Z8j0zPzmCGJDBHCsr9PZaZcF//RZHw727xonj+icZ5T1HGQbxDzwE4mBQHveSVGH2YYBkC9x2dBcpaaDVXQ5jLauNaY2gvsp4C57cBd9YcTQXVu6vwy+Wie7b7f92u301XWu27Gi01dUvtmdDDj0y6juP+5thOwnmU1sutfdkCIIACtqAsPTuuXzsllnCeOH3al5DQlAkq+pK6/63ueLhyKWw7ElD3rqKfDTR36XI1ZRZp7p6UVazYYtHu4bcZ29jGupOEdAGSzwNoV8YECrusNOqDFMdhW0otHp8Txso=;M/Sngbfs/QMyzfKkUF7c3g=="
---

